Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lustre Skin, formerly known as Ambicare Health, is a UK medical device and consumer health company developing wearable LED light therapy products for dermatology. The company was founded in 2004 as a spin-out from the University of St Andrews, NHS Tayside/Ninewells Hospital, and InnoScot Health. Its core product families include Ambulight PDT for non-melanoma skin cancer treatment in clinical settings and LUSTRE ClearSkin devices for acne and other skin applications in consumer and clinic channels. The business focuses on flexible, wearable light-based therapies that make phototherapy more convenient than traditional clinic-based systems. Ambicare is therefore a real healthcare company match, but its current operating name is Lustre Skin rather than Ambicare Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lustre Skin.